• 13166 Citations
  • 40 h-Index
1973 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Lymphogranulomatosisos betegek K (killer) sejt aktivitása.

Láng, I., Berényi, E., Szegedi, G., Fekete, B., Török, K., Kalmár, L. & Nékám, K., szept. 10 1978, In : Orvosi hetilap. 119, 37, p. 2249-2250 2 p.

Research output: Article

1 Citation (Scopus)

memo: Spectacular developments during the last decade from the Section Editors’ point of view

Hofer, S., Gunsilius, E., Láng, I. & Moiseyenko, V., febr. 1 2017, In : Memo - Magazine of European Medical Oncology. 10, 1, p. 4-7 4 p.

Research output: Editorial

Metothyrin indukált agranulocytosis kezelése granulocyta-macrophag colonia stimuláló faktorral.

Somogyi, A., Werling, K., Rosta, A. & Láng, I., nov. 6 1994, In : Orvosi hetilap. 135, 45, p. 2483-2485 3 p.

Research output: Article

2 Citations (Scopus)

Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A phase 2, randomised, double-blind, placebo-controlled study

Martin, M., Roche, H., Pinter, T., Crown, J., Kennedy, M. J., Provencher, L., Priou, F., Eiermann, W., Adrover, E., Lang, I., Ramos, M., Latreille, J., Jagiełło-Gruszfeld, A., Pienkowski, T., Alba, E., Snyder, R., Almel, S., Rolski, J., Munoz, M., Moroose, R. & 9 others, Hurvitz, S., Baños, A., Adewoye, H., Hei, Y. J., Lindsay, M. A., Rupin, M., Cabaribere, D., Lemmerick, Y. & Mackey, J. R., ápr. 2011, In : The Lancet Oncology. 12, 4, p. 369-376 8 p.

Research output: Article

72 Citations (Scopus)

Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: The FLAGS trial

Ajani, J. A., Rodriguez, W., Bodoky, G., Moiseyenko, V., Lichinitser, M., Gorbunova, V., Vynnychenko, I., Garin, A., Lang, I. & Falcon, S., márc. 20 2010, In : Journal of Clinical Oncology. 28, 9, p. 1547-1553 7 p.

Research output: Article

434 Citations (Scopus)

Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00

Munzone, E., Gray, K. P., Fumagalli, C., Guerini-Rocco, E., Láng, I., Ruhstaller, T., Gianni, L., Kammler, R., Viale, G., Di Leo, A., Coates, A. S., Gelber, R. D., Regan, M. M., Goldhirsch, A., Barberis, M. & Colleoni, M., júl. 1 2018, In : Breast Cancer Research and Treatment. 170, 2, p. 351-360 10 p.

Research output: Article

2 Citations (Scopus)

Myasthenia in a patient with sarcoidosis and schizophrenia.

Rózsa, C., Kis, G., Komoly, S., Anselmo, V., Esik, O., Láng, I., Kas, J., Németh, G., Solymosi, D., Svasztics, E., Szentirmay, Z., Szobor, A. & Telekes, A., júl. 20 2004, In : Ideggyógyászati szemle. 57, 7-8, p. 242-244 3 p.

Research output: Article

5 Citations (Scopus)

Null-sejtes Sezary-syndroma.

Szigeti, A., Fazakas, L., Fekete, B., Nékám, K., Láng, I. & Gergely, P., júl. 29 1979, In : Orvosi hetilap. 120, 30, p. 1825-1827 3 p.

Research output: Article

O{double acute}rszemnyirokcsomó-biopszia neoadjuváns kemoterápiát igénylo{double acute} emlo{double acute}rákoknál

Mátrai, Z., Tóth, L., Polgár, C., Láng, I., Godény, M., Sinkovics, I., Horváth, Z., Bidlek, M., Udvarhelyi, N., Bartal, A., Sávolt, Á., Újhelyi, M. & Kásler, M., 2011, In : Magyar onkologia. 55, 2, p. 73-84 12 p.

Research output: Article

1 Citation (Scopus)

Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial

Ewertz, M., Gray, K. P., Regan, M. M., Ejlertsen, B., Price, K. N., Thürlimann, B., Bonnefoi, H., Forbes, J. F., Paridaens, R. J., Rabaglio, M., Gelber, R. D., Colleoni, M., Láng, I., Smith, I. E., Coates, A. S., Goldhirsch, A. & Mouridsen, H. T., nov. 10 2012, In : Journal of Clinical Oncology. 30, 32, p. 3967-3975 9 p.

Research output: Article

74 Citations (Scopus)

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: Results of the CECOG LaVie trial

Thallinger, C., Lang, I., Kuhar, C. G., Bartsch, R., Singer, C. F., Petruzelka, L., Melichar, B., Knittelfelder, R., Brodowicz, T. & Zielinski, C., febr. 18 2016, In : BMC cancer. 16, 1, 121.

Research output: Article

4 Citations (Scopus)

Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial

On behalf of CALOR trial investigators, febr. 1 2017, In : Annals of Surgical Oncology. 24, 2, p. 398-406 9 p.

Research output: Article

13 Citations (Scopus)

Predictive role of hand-foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer

Zielinski, C., Lang, I., Beslija, S., Kahan, Z., Inbar, M. J., Stemmer, S. M., Anghel, R., Vrbanec, D., Messinger, D. & Brodowicz, T., jan. 19 2016, In : British journal of cancer. 114, 2, p. 163-170 8 p.

Research output: Article

12 Citations (Scopus)

Predictive Value of Early Skin Rash in Cetuximab-Based Therapy of Advanced Biliary Tract Cancer

Rubovszky, G., Budai, B., Ganofszky, E., Horváth, Z., Juhos, É., Madaras, B., Nagy, T., Szabó, E., Pintér, T., Tóth, E., Nagy, P., Láng, I. & Hitre, E., ápr. 1 2018, In : Pathology and Oncology Research. 24, 2, p. 237-244 8 p.

Research output: Article

5 Citations (Scopus)

predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab

Duchnowska, R., Sperinde, J., Czartoryska-Arlukowicz, B., Myśliwiec, P., Winslow, J., Radecka, B., Petropoulos, C., Demlova, R., Orlikowska, M., Kowalczyk, A., Láng, I., Ziółkowska, B., Debska-Szmich, S., Merdalska, M., Grela-Wojewoda, A., Zawrocki, A., Biernat, W., Huang, W. & Jassem, J., jan. 1 2017, In : Oncotarget. 8, 61, p. 104149-104159 11 p.

Research output: Article

7 Citations (Scopus)

Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial

Mauriac, L., Keshaviah, A., Debled, M., Mouridsen, H., Forbes, J. F., Thürlimann, B., Paridaens, R., Monnier, A., Láng, I., Wardley, A., Nogaret, J. M., Gelber, R. D., Castiglione-Gertsch, M., Price, K. N., Coates, A. S., Smith, I., Viale, G., Rabaglio, M., Zabaznyi, N. & Goldhirsch, A., máj. 2007, In : Annals of Oncology. 18, 5, p. 859-867 9 p.

Research output: Article

112 Citations (Scopus)

Preoperative work up and therapeutic schedule for patients with duplex tumors.

Jobaházi, J., Láng, I., Szentpétery, F. & Jakab, F., 1997, In : Acta Chirurgica Hungarica. 36, 1-4, p. 147-149 3 p.

Research output: Article

Preoperatív kemoterápia a colorectalis májáttétes betegek sebészi kezelésében

Dede, K., Láng, I., Pörneczi, B., Mester, G., Fekete, A., Kőszegi, G., Mersich, T., Besznyák, I. & Bursics, A., dec. 1 2013, In : Magyar sebészet. 66, 6, p. 325-330 6 p.

Research output: Article

1 Citation (Scopus)

Progress on BIG 1-02/IBCSG 27-02/NSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer

Wapnir, I. L., Aebi, S., Gelber, S., Anderson, S. J., Láng, I., Robidoux, A., Mamounas, E. P. & Wolmark, N., nov. 2008, In : Annals of Surgical Oncology. 15, 11, p. 3227-3231 5 p.

Research output: Article

23 Citations (Scopus)

Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin

Láng, I., Köhne, C. H., Folprecht, G., Rougier, P., Curran, D., Hitre, E., Sartorius, U., Griebsch, I. & Van Cutsem, E., jan. 1 2013, In : European Journal of Cancer. 49, 2, p. 439-448 10 p.

Research output: Article

42 Citations (Scopus)

Radio-guided resection of non-palpable rectal carcinoma following polypectomy

Mersich, T., Lang, I., Balogh, I. & Jakob, F., ápr. 1 2007, In : Hepato-Gastroenterology. 54, 75, p. 751-752 2 p.

Research output: Article

5 Citations (Scopus)

Retroperitoneális plazmasejtes óriás nyirokcsomó hiperplázia.

Láng, I., Kopper, L., Magyarosy, E. & Petrányi, G., máj. 10 1981, In : Orvosi hetilap. 122, 19, p. 1139-1141 3 p.

Research output: Article

Retroperitoneal plasmocytic giant lymph node hyperplasia

Lang, I., Kopper, L., Magyarosy, E., Lapis, K. & Petrányi, G., dec. 1 1984, In : Journal of the Royal Society of Medicine. 77, 6, p. 517-519 3 p.

Research output: Article

1 Citation (Scopus)

Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: Primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)

Jerusalem, G., Mariani, G., Ciruelos, E. M., Martin, M., Tjan-Heijnen, V. C. G., Neven, P., Gavila, J. G., Michelotti, A., Montemurro, F., Generali, D., Simoncini, E., Lang, I., Mardiak, J., Naume, B., Camozzi, M., Lorizzo, K., Bianchetti, S. & Conte, P., szept. 1 2016, In : Annals of Oncology. 27, 9, p. 1719-1725 7 p.

Research output: Article

26 Citations (Scopus)

Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer

Lang, I., Inbar, M. J., Kahán, Z., Greil, R., Beslija, S., Stemmer, S. M., Kaufman, B., Zvirbule, Z., Steger, G. G., Messinger, D., Brodowicz, T. & Zielinski, C., nov. 1 2012, In : European Journal of Cancer. 48, 17, p. 3140-3149 10 p.

Research output: Article

11 Citations (Scopus)

Sebészi onkológia

Ferenc, J. & István, L., dec. 15 2008, In : Orvoskepzes. 83, 3, p. 281-285 5 p.

Research output: Review article

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

Brodowicz, T., Lang, I., Kahan, Z., Greil, R., Beslija, S., Stemmer, S. M., Kaufman, B., Petruzelka, L., Eniu, A., Anghel, R., Koynov, K., Vrbanec, D., Pienkowski, T., Melichar, B., Spanik, S., Ahlers, S., Messinger, D., Inbar, M. J. & Zielinski, C., nov. 25 2014, In : British journal of cancer. 111, 11, p. 2051-2057 7 p.

Research output: Article

17 Citations (Scopus)
1 Citation (Scopus)

Significance of histomorphology of early triple-negative breast cancer

Rubovszky, G., Horváth, Z., Tóth, E., Láng, I. & Kásler, M., okt. 1 2012, In : Pathology and Oncology Research. 18, 4, p. 823-831 9 p.

Research output: Article

2 Citations (Scopus)
35 Citations (Scopus)

Silymarin kezelés immunmoduláns hatása krónikus alkoholos májbetegségben.

Deák, G., Müzes, G., Láng, I., Niederland, V., Nékám, K., Gonzalez-Cabello, R., Gergely, P. & Fehér, J., jún. 17 1990, In : Orvosi hetilap. 131, 24, p. 1291-1292, 1295

Research output: Review article

9 Citations (Scopus)

Silymarin kezelés májvédö hatása idült alkoholos májbetegségben.

Fehér, J., Deák, G., Müzes, G., Láng, I., Niederland, V., Nékám, K. & Kárteszi, M., dec. 17 1989, In : Orvosi hetilap. 130, 51, p. 2723-2727 5 p.

Research output: Review article

88 Citations (Scopus)

Simultaneous insulin immunoassay in sera, heparin and EDTA plasma

Balaszi, I., Stutzel, M., Littmann, L. & Lang, I., dec. 1 1974, In : REV.ROUM.MED.. 12, 3, p. 175-180 6 p.

Research output: Article

SLE-s és metasztatizáló szolid tumoros betegek természetes és lektin-dependens sejtes citotoxicitásának vizsgálata.

Perl, A., Rhenso, G. C., Láng, I., Nékám, K. & Gergely, P., jan. 15 1984, In : Orvosi hetilap. 125, 3, p. 135-137 3 p.

Research output: Article

9 Citations (Scopus)

Survival outcomes of the NeoALTTO study (BIG 1–06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer

Huober, J., Holmes, E., Baselga, J., de Azambuja, E., Untch, M., Fumagalli, D., Sarp, S., Lang, I., Smith, I., Boyle, F., Xu, B., Lecocq, C., Wildiers, H., Jouannaud, C., Hackman, J., Dasappa, L., Ciruelos, E., Toral Pena, J. C., Adamchuk, H., Hickish, T. & 5 others, de la Pena, L., Jackisch, C., Gelber, R. D., Piccart-Gebhart, M. & Di Cosimo, S., szept. 2019, In : European Journal of Cancer. 118, p. 169-177 9 p.

Research output: Article

4 Citations (Scopus)

Symptoms of endocrine treatment and outcome in the BIG 1-98 study

Huober, J., Cole, B. F., Rabaglio, M., Giobbie-Hurder, A., Wu, J., Ejlertsen, B., Bonnefoi, H., Forbes, J. F., Neven, P., Láng, I., Smith, I., Wardley, A., Price, K. N., Goldhirsch, A., Coates, A. S., Colleoni, M., Gelber, R. D. & Thürlimann, B., jan. 2014, In : Breast Cancer Research and Treatment. 143, 1, p. 159-169 11 p.

Research output: Article

20 Citations (Scopus)

Systemás lupus erythematosusban szenvedö betegek antitesttöl függö, sejthez kötött cytotocicitásáról.

Láng, I., Fekete, B., Török, K., Pálóczi, K., Sonkoly, I., Szegedi, G. & Gergely, P., júl. 30 1978, In : Orvosi hetilap. 119, 31, p. 1885-1887 3 p.

Research output: Article

The ADCC activity of malignant tumor patients

Lang, I., Fekete, B. & Petranyi, J., jan. 1 1978, In : Magyar onkologia. 22, 3, p. 189-194 6 p.

Research output: Article

The ADCC activity of malignant tumor patients following radiotherapy

Lang, I., Petranyi, J. & Fekete, B., jan. 1 1978, In : Magyar onkologia. 22, 3, p. 184-188 5 p.

Research output: Article

1 Citation (Scopus)

The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer

Afzal, S., Gusella, M., Jensen, S. A., Vainer, B., Vogel, U., Andersen, J. T., Brødbæk, K., Petersen, M., Jimenez-Solem, E., Adleff, V., Budai, B., Hitre, E., Lng, I., Orosz, E., Bertolaso, L., Barile, C., Padrini, R., Kralovnszky, J., Pasini, F. & Poulsen, H. E., szept. 1 2011, In : Pharmacogenomics. 12, 9, p. 1257-1267 11 p.

Research output: Article

28 Citations (Scopus)

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): A randomised phase 2 study

Finn, R. S., Crown, J. P., Lang, I., Boer, K., Bondarenko, I. M., Kulyk, S. O., Ettl, J., Patel, R., Pinter, T., Schmidt, M., Shparyk, Y., Thummala, A. R., Voytko, N. L., Fowst, C., Huang, X., Kim, S. T., Randolph, S. & Slamon, D. J., jan. 1 2015, In : The Lancet Oncology. 16, 1, p. 25-35 11 p.

Research output: Article

991 Citations (Scopus)
3 Citations (Scopus)

The effect of transfer factor on spontaneous shedding of sheep red blood cell binding receptors of T lymphocytes in vitro

Nekam, K., Varro, R., Torok, K., Láng, I., Kalmár, L., Gergely, P. & Petrányi, G., dec. 1 1980, In : Acta medica Academiae Scientiarum Hungaricae. 37, 1, p. 83-88 6 p.

Research output: Article

The effect of transfer factor therapy on antibody dependent cellular cytotoxicity

Lang, I., Nekam, K., Torok, K. & Gergely, P., jan. 1 1979, In : Orvosi hetilap. 120, 25, p. 1491-1495 5 p.

Research output: Article